Fiera Capital Corp Has $302,000 Position in Monsanto Company (MON)
Fiera Capital Corp held its position in Monsanto Company (NYSE:MON) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,550 shares of the basic materials company’s stock at the end of the 2nd quarter. Fiera Capital Corp’s holdings in Monsanto were worth $302,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in MON. BlackRock Inc. raised its stake in shares of Monsanto by 2,390.1% during the 1st quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after purchasing an additional 25,140,936 shares during the period. OZ Management LP bought a new stake in shares of Monsanto during the 2nd quarter worth $242,786,000. York Capital Management Global Advisors LLC raised its stake in shares of Monsanto by 58.4% during the 1st quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after purchasing an additional 1,506,057 shares during the period. Flossbach Von Storch AG raised its stake in shares of Monsanto by 33.9% during the 1st quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock worth $462,920,000 after purchasing an additional 1,034,400 shares during the period. Finally, PSquared Asset Management AG raised its stake in shares of Monsanto by 239.0% during the 2nd quarter. PSquared Asset Management AG now owns 1,274,320 shares of the basic materials company’s stock worth $150,829,000 after purchasing an additional 898,395 shares during the period. Institutional investors own 74.78% of the company’s stock.
Monsanto Company (NYSE MON) opened at 119.40 on Friday. The firm’s 50-day moving average price is $117.37 and its 200-day moving average price is $116.53. The stock has a market cap of $52.46 billion, a price-to-earnings ratio of 25.79 and a beta of 1.07. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $119.60.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. During the same quarter last year, the company earned $2.17 earnings per share. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, equities analysts predict that Monsanto Company will post $4.89 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is currently 46.75%.
In other news, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the transaction, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.
A number of equities research analysts have recently commented on the company. UBS AG cut Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a research note on Thursday, September 14th. Royal Bank Of Canada reiterated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, August 2nd. Jefferies Group LLC cut Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a research note on Wednesday, July 12th. Finally, Barclays PLC lifted their target price on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. Ten investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $124.09.
COPYRIGHT VIOLATION WARNING: This report was originally published by Daily Political and is the property of of Daily Political. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.dailypolitical.com/2017/09/22/fiera-capital-corp-has-302000-position-in-monsanto-company-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.